Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Moat Score: 0/10 (As of Jul. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600867 Tonghua Dongbao Pharmaceutical Co Ltd SHSE:600867
83 GF Score
Price ¥8.17
GF Value ¥10.28
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Tonghua Dongbao Pharmaceutical Co Moat Score?

Tonghua Dongbao Pharmaceutical Co has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Tonghua Dongbao Pharmaceutical Co has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Tonghua Dongbao Pharmaceutical Co might have No Moat - No discernible moat.


Tonghua Dongbao Pharmaceutical Co  (SHSE:600867) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Tonghua Dongbao Pharmaceutical Co Moat Score Related Terms

SHSE:600867
83GF Score
Tonghua Dongbao Pharmaceutical Co Ltd SHSE:600867
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Overvalued in 2026?

Based on GuruFocus' analysis, Tonghua Dongbao Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.17 is trading 20.5% below its estimated GF Value™ of ¥10.28. GuruFocus considers Tonghua Dongbao Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600867:

  • Moat Score: 0
  • GF Value™: ¥10.28 vs. price of ¥8.17 (20.5% below fair value)
  • GF Score™: 83/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600867 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tonghua Dongbao Pharmaceutical Co Business Description

Address Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
83GF Score

Get the complete analysis for SHSE:600867

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.17
Price
¥10.28
GF Value